SIGA Announces U.S. Government Procurement Order of $113 Million for Oral TPOXX®
19. Juli 2024 08:00 ET
|
SIGA Technologies Inc.
NEW YORK, July 19, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that the U.S. Department of Health and Human...
SIGA Announces Agreement to Sell TPOXX® to ASEAN Member States
17. Juni 2024 16:05 ET
|
SIGA Technologies Inc.
NEW YORK, June 17, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc., a commercial-stage pharmaceutical company focused on global health and infectious diseases, announced today an agreement to...
SIGA Reports Financial Results for Three Months Ended March 31, 2024
07. Mai 2024 16:05 ET
|
SIGA Technologies Inc.
Generated Product Sales of $24 Million and Pre-tax Operating Income of $11 MillionCorporate Update Conference Call Today at 4:30 PM ET NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies,...
SIGA Technologies to Host Business Update Call on May 7 Following Release of First-Quarter 2024 Financial Results
01. Mai 2024 17:00 ET
|
SIGA Technologies Inc.
NEW YORK, May 01, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and...
SIGA Amends International Promotion Agreement with Meridian to Enhance International Growth Opportunities of Oral TPOXX®
01. April 2024 16:05 ET
|
SIGA Technologies Inc.
NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on health security and infectious disease, announced today that...
SIGA Names Larry Miller General Counsel
25. März 2024 07:30 ET
|
SIGA Technologies Inc.
NEW YORK, March 25, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on health security and infectious diseases, announced the...
SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2023
12. März 2024 16:05 ET
|
SIGA Technologies Inc.
• Increased Product Sales to $131 Million in 2023 • Grew Pre-tax Operating Income to $84 Million in 2023 • Declared Today a Special Cash Dividend of $0.60 per Share • Corporate Update Conference...
SIGA Declares Special Cash Dividend of $0.60 Per Share
12. März 2024 07:30 ET
|
SIGA Technologies Inc.
NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that its board of directors declared a special...
SIGA Technologies to Host Business Update Call on March 12th, 2024 Following Release of Fourth Quarter and Full Year 2023 Financial Results
05. März 2024 07:30 ET
|
SIGA Technologies Inc.
NEW YORK, March 05, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and...
SIGA Announces Appointment of Diem Nguyen, Ph.D., MBA, as New Chief Executive Officer
22. Januar 2024 07:30 ET
|
SIGA Technologies Inc.
NEW YORK, Jan. 22, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Diem...